Odyssey Therapeutics, Inc. ($ODTX)
Filing Information
| Accession Number | 0001012975-26-000417 |
|---|---|
| Form Type | 4 |
| Filing Date | May 12, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
19,432,280
Total Value
$19,999,998.00
P&L
-0.3% ($66,666.66)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | May 8, 2026 | Conversion | 1,709,543 | โ | โ | 2,222,405 | Direct | โ | View Details | |
Director | Common Stock | โ | May 8, 2026 | Purchase | 1,111,111 | $18.00 | $19,999,998.00 | 3,333,516 | Direct | โ | View Details | |
Director | Series D Convertible Preferred Stock | Derivative | May 8, 2026 | Conversion | 16,611,626 | โ | โ | 0 | Direct | โ | View Details |